Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis

Neurol Sci. 2023 Apr;44(4):1393-1399. doi: 10.1007/s10072-022-06541-7. Epub 2022 Dec 9.

Abstract

Background: Hereditary cranial hyperostosis is a rare disease never described in Italy, so the neurological manifestations in patients and carriers of the disease have been little studied.

Methods: We describe the neurological and neuroimaging features of patients and carriers of the gene from a large Italian family with sclerosteosis.

Results: In this family, genetic testing detected the homozygous p.Gln24X (c.70C > T) mutation of the SOST gene in the proband and a heterozygous mutation in 9 siblings. In homozygous adults, severe craniofacial hyperostosis was manifested by cranial neuropathy in childhood, chronic headache secondary to intracranial hypertension, and an obstructive sleep apnea syndrome in adults. In one of the adult patients, there was a compressible subcutaneous swelling in the occipital region caused by transosseous intracranial-extracranial occipital venous drainage, a compensation mechanism of obstructed venous drainage secondary to cranial hyperostosis. Mild cranial hyperostosis causing frequent headache and snoring was evident in the nine heterozygous subjects.

Conclusions: Multiple cranial neuropathies and headache in children, while severe chronic headache and sleep disturbances in adults, are the neurological manifestations of the first Italian family with osteosclerosis. It is reasonable to extend neurological and neuroimaging evaluation to gene carriers as well.

Keywords: Headache; Hereditary cranial hyperostosis; Intracranial hypertension; Obstructive sleep apnea; Sclerosteosis.

MeSH terms

  • Adult
  • Bone Morphogenetic Proteins / genetics
  • Child
  • Genetic Markers
  • Headache
  • Humans
  • Hyperostosis* / complications
  • Hyperostosis* / diagnostic imaging
  • Hyperostosis* / genetics
  • Osteosclerosis* / diagnostic imaging
  • Osteosclerosis* / genetics

Substances

  • Bone Morphogenetic Proteins
  • Genetic Markers